ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
7.93
-0.22 (-2.70%)
May 18, 2026, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $820.89 million as of May 18, 2026. Its market cap has increased by 107.32% in one year.
Market Cap
820.89M
Enterprise Value
545.69M
1-Year Change
107.32%
Ranking
Category
Stock Price
$7.93
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $820.89M, an increase of 10.64%. That is a compound annual growth rate of 1.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 843.67M | 5.90% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 846.79M |
| Sana Biotechnology | 846.01M |
| Theravance Biopharma | 838.25M |
| Seaport Therapeutics | 834.66M |
| Aura Biosciences | 823.94M |
| Arbutus Biopharma | 823.73M |
| Odyssey Therapeutics | 820.36M |
| Xencor | 820.01M |